🇺🇸 FDA
Pipeline program

SKY0402 300mg in healthy patients

SKY0402C110

Phase 1 small_molecule completed

Quick answer

SKY0402 300mg in healthy patients for Pain is a Phase 1 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Pain
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials